KRASG12D-IN-8
KRASG12D-IN-8 is an orally active KRASG12D inhibitor, with a Kd value of 0.003 nM for KRASG12D and 0.024 nM for KRASG12V. KRASG12D-IN-8 inhibits the activity of phosphorylated ERK in KRAS-mutated cells. KRASG12D-IN-8 induces tumor regression in ovarian cancer xenograft mouse models. KRASG12D-IN-8 can be used for the research of KRAS-mutated cancers.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3101973-42-3
- 화학식: C35H37F3N6O4
- 분자량:662.70
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
KRas G12D 0.003 nM (Ki) |
KRas G12V 0.024 nM (Ki) |
KRASG12D-IN-8 (Compound 12) binds to KRASG12D with a Kd of 0.003 nM and to KRASG12V with a Kd of 0.024 nM, exhibiting exceptional high-affinity interactions with both mutant KRAS proteins[1].
KRASG12D-IN-8 has a low efflux permeability of 15.4 ×10−6 cm/s in MDCK cells, with intrinsic clearance values of 338 μL/min/mg in human liver microsomes and 542 μL/min/mg in mouse liver microsomes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:RKN tumor bearing SCID-Beige mice[1]
-
Dosage:0.3-3 mg/kg
-
Administration:p.o.; once daily; 2 weeks
-
Result:Inhibited RKN tumor growth in a dose-dependent manner, with tumor inhibition of 38.8%, tumor
regression of -45.2% and -89.4% across 0.3, 1 and 3 mpk dose, respectively.
Were well tolerated without body weight loss[1].
Chemical Information
-
CAS No. 3101973-42-3
-
분자량 662.70
-
화학식 C35H37F3N6O4
-
SMILES
C[C@@]12CCCN(C3=NC(OC[C@@]45CCCN4C[C@@H](C5)F)=NC6=C(C(C7=CC(O)=CC8=CC=C(C(CCCOC(N2)=O)=C78)F)=NC=C36)F)C1
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)